Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118480026A reveals high-yield synthesis for lipoic acid impurity A. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel method for synthesizing intramolecular thioether impurities of sugammadex sodium using mild conditions. Enhances quality control and supply chain stability for API manufacturers.
Novel preparation methods for Futamtinib impurities ensure rigorous quality control. Enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110818576B reveals a novel rare earth catalyzed synthesis of secondary amines. High yield, mild conditions, and cost-effective supply chain solutions for pharma.
Patent CN110790755A reveals a novel high-yield route for Canagliflozin Peroxide, offering significant cost reduction and supply reliability for SGLT2 inhibitor manufacturers.
Novel triflate catalyst method for Clindamycin 3,4-isopropylidene. High yield, low waste, reliable pharmaceutical intermediates supplier for global supply chains.
Patent CN108101841B details a controlled hydrogenation method for Indacaterol, significantly reducing Impurity A and enhancing manufacturing efficiency for global supply chains.
Patent CN102464589A details a high-yield route for Rasagiline mesylate using chiral aminolysis and alkylation, offering significant cost reduction in API manufacturing.
Novel 10-step route for fondaparinux sodium disaccharide fragment. Reduces steps, uses water solvent, enhances supply chain reliability for pharmaceutical intermediates.
Patent CN113248356A reveals a scalable two-step route for 4-hydroxy-1-indanone, offering cost reduction in pharmaceutical intermediate manufacturing via mild acid catalysis.
Novel synthesis of trifluoromethylthio indanones via persulfate oxidation. Offers high yield, purity, and scalable process for pharmaceutical intermediate manufacturing.
Patent CN109096206A details a high-purity Carbendazim synthesis method using acidic photocatalysis, offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN113804805A details a solvent-free method for synthesizing Pregabalin Impurity II. Achieve >99% purity for QC standards with reduced environmental impact.
Patent CN107935910A reveals novel tandem synthesis for high-purity oxindole derivatives offering substantial cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN117567288A details a novel asymmetric hydrogenation process for chiral alcohols, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN114380750B reveals high-yield deuteration route. Enhances supply chain reliability and reduces manufacturing costs for veterinary and pharmaceutical intermediates.
Patent CN109096126B details a mild, high-yield synthesis for D9-Clenbuterol. Discover cost-effective production strategies for high-purity isotopic standards.
Novel synthesis route for Bcr-Abl inhibitor intermediates offering cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN111320712B details a novel synthesis for Sugammadex intramolecular thioether impurities, offering high-purity reference standards and streamlined manufacturing for global pharmaceutical supply chains.
Patent CN110903247B reveals a urea peroxide oxidation method for oxfendazole, significantly reducing impurity B and enhancing safety for veterinary pharmaceutical manufacturing.